display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced - colorectal cancer (mCRC)endometrial cancer - (neo)adjuvant (NA)
endometrial cancerendometrial cancer - (neo)adjuvant (NA)
immune chekpoint inhibitors
anti-PD-(L)1
atezolizumab based treatment
atezolizumab plus SoC AtTEnd
avelumab based treatment
avelumab plus SoC MITO END-3
dostarlimab based treatment
dostarlimab plus soC RUBY ... RUBY ...
durvalumab based treatment
durvalumab plus olaparib plus SoC DUO-E ...
durvalumab plus SoC DUO-E ...
pembrolizumab based treatment
pembrolizumab plus lenvatinib LEAP-001/ENGOT-en9 KEYNOTE-775
pembrolizumab plus SoC NRG-GY018_dMMR NRG-GY018_pMMR KEYNOTE-B21

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons